Successful treatment with nivolumab in a patient with lung adenocarcinoma complicated by pulmonary aspergilloma

Immune checkpoint inhibitors (ICIs) are the key drugs used in patients with non‐small cell lung cancer (NSCLC). However, anti‐PD‐1 therapy might worsen chronic infection by reactivating the immune response to infectious diseases. Here, we describe a case of successful treatment with nivolumab in a p...

Descripción completa

Detalles Bibliográficos
Autores principales: Furuya, Naoki, Kojima, Koji, Marushima, Hideki, Kakinuma, Kazutaka, Tsunoda, Akihito, Koda, Eriko, Tsuruoka, Hajime, Nishida, Kohei, Inoue, Takeo, Saji, Hisashi, Mineshita, Masamichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605990/
https://www.ncbi.nlm.nih.gov/pubmed/32941695
http://dx.doi.org/10.1111/1759-7714.13662